Janux Therapeutics (JANX) Times Interest Earned (2020)
Janux Therapeutics (JANX) reported Times Interest Earned of -$10.15 for Q2 2020.
Janux Therapeutics (JANX) has 1 years of Times Interest Earned data on file, last reported at -$10.15 in Q2 2020.
- Quarterly Times Interest Earned changed N/A year-over-year to -$10.15 in Q2 2020, while the trailing twelve-month figure through Mar 2021 was -$57.81 (changed N/A YoY) and the FY2020 annual result came in at -$23.51, changed N/A from the prior year.
- Times Interest Earned held at -$10.15 in Q2 2020 per JANX's latest filing.
- Across five years, Times Interest Earned topped out at -$10.15 in Q2 2020 and bottomed at -$10.15 in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 3.88 |
| 10 | Janux Therapeutics | 914.29 Mn | 914.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -10.15 |